Clinical Trials
12 trialsNCT05470283 2026-04-16
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT06899061 2026-03-27
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
AstraZeneca
Phase 1 Active not recruiting
NCT04706910 2026-02-09
18F-DOPA II - PET Imaging Optimization
University of Alberta
Phase 3 Recruiting
NCT07167862 2026-01-23
PPPOCUS
University of California, Irvine
Phase 4 Not yet recruiting
NCT05741372 2026-01-13
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Boehringer Ingelheim
Phase NA Completed
NCT05779943 2025-10-27
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer
Emory University
Phase 2 Active not recruiting
NCT02356159 2025-09-30
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT06407401 2024-11-05
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Not yet recruiting
NCT02501213 2019-05-16
Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)
Centre Oscar Lambret
Phase 2 Terminated
NCT02712476 2016-03-18
Brain Relaxation With Mannitol and Furosemide
Istanbul University
Phase NA Completed
NCT02373735 2015-12-30
Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes
Asan Medical Center
Phase NA Completed
NCT01508260 2013-04-05
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload
M.D. Anderson Cancer Center
Phase NA Withdrawn